The Hematopoietic Cell Transplant Comorbidity Index predicts survival after allogeneic transplant for nonmalignant diseases. - Abstract - Europe PMC
The Hematopoietic Cell Transplant Comorbidity Index predicts survival after allogeneic transplant for nonmalignant diseases. - Abstract - Europe PMC
A high hematopoietic cell transplantation comorbidity Index (HCT-CI) does not impair outcomes after non-myeloablative allogeneic stem cell transplantation in acute myeloid leukemia patients 60 years or older | Bone Marrow Transplantation
Pre-transplant Comorbidities: Influence on Decision-Making and Outcomes | SpringerLink
A modified EBMT risk score and the hematopoietic cell transplantation-specific comorbidity index for pre-transplant risk assessment in adult acute lymphoblastic leukemia | Haematologica
Current Challenges and New Opportunities in Hematopoietic Stem Cell T…
Parameters of the HCT-CI 6 and their distribution (387 patients | Download Table
Pulmonary Function and Pretransplant Evaluation of the Hematopoietic Cell Transplant Candidate
Myeloma in Elderly Patients: When Less Is More and More Is More | American Society of Clinical Oncology Educational Book
HCT-CI: Hematopoietic Cell Transplantation-Comorbidity Index 'Sorror Score'
PDF) Prospective Validation of the Predictive Power of the Hematopoietic Cell Transplantation Comorbidity Index: A CIBMTR® Study
A modified EBMT risk score and the hematopoietic cell transplantation-specific comorbidity index for pre-transplant risk assessment in adult acute lymphoblastic leukemia | Haematologica
Presentazione standard di PowerPoint
Age adjusted hematopoietic stem cell transplant comorbidity index predicts survival in a T-cell depleted cohort - ScienceDirect
A concise revised Myeloma Comorbidity Index as a valid prognostic instrument in a large cohort of 801 multiple myeloma patients
Application of the CIBMTR Survival Outcomes Calculator to CD34-Selected Allogeneic HCT for Acute Leukemia and Myelodysplastic Syndrome - Biology of Blood and Marrow Transplantation
Comparison of the Prognostic Ability of the HCT-CI, the Modified EBMT, and the EBMT-ADT Pre-transplant Risk Scores for Acute Leukemia - Clinical Lymphoma, Myeloma and Leukemia
A high hematopoietic cell transplantation comorbidity Index (HCT-CI) does not impair outcomes after non-myeloablative allogeneic stem cell transplantation in acute myeloid leukemia patients 60 years or older | Bone Marrow Transplantation
How I assess comorbidities before hematopoietic cell transplantation. - Abstract - Europe PMC
Comorbidity-age index: a clinical measure of biologic age before allogeneic hematopoietic cell transplantation. | Semantic Scholar
Age adjusted hematopoietic stem cell transplant comorbidity index predicts survival in a T-cell depleted cohort - ScienceDirect
Presentazione standard di PowerPoint
Comorbidity-age index: a clinical measure of biologic age before allogeneic hematopoietic cell transplantation. | Semantic Scholar
Comparison of Risk Scoring Systems in HLA-Matched Related Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective C
Comorbidity-age index: a clinical measure of biologic age before allogeneic hematopoietic cell transplantation. | Semantic Scholar
Table 1 from The HCT-CI and Other Traditional Risk Factors for HCT Outcomes | Semantic Scholar
